Literature DB >> 19800639

Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.

Georges Saab1, Adam Whaley-Connell, Samy I McFarlane, Suying Li, Shu-Cheng Chen, James R Sowers, Peter A McCullough, George L Bakris.   

Abstract

The objective of the study was to examine the relationship of obesity and parathyroid hormone (PTH) levels among persons with chronic kidney disease (CKD). This was a cross-sectional analysis of 4551 participants in the National Kidney Foundation-Kidney Early Evaluation Program found to have CKD (estimated glomerular filtration rate <60 mL/[min 1.73 m(2)]) examining the relationship of body mass index (BMI) and PTH levels. In unadjusted analysis, PTH levels increased with increasing BMI quartiles. After adjustment for age, race, sex, diabetes, calcium, phosphorus, estimated glomerular filtration rate, and presence of microalbuminuria, PTH levels were 7.3% (P = .008), 11.9% (P < .0001), and 18.1% (P < .0001) higher in the second, third, and fourth BMI quartiles, respectively, as compared with the first quartile. In a companion analysis, higher BMI was associated with increased odds of having an elevated PTH measurement (>70 pg/mL). Compared with the first quartile, odds ratios for elevated PTH were 1.26 (95% confidence interval, 1.06-1.50; P = .01), 1.38 (1.15-1.65, P = .0005), and 1.66 (1.37-2.00, P < .0001) for the second, third, and fourth quartiles, respectively. We found no effect modification by race, diabetes, or presence of microalbuminuria. Therefore, in a large community-dwelling population with CKD, the presence of obesity and of increasing BMI is associated with higher PTH levels independent of measured confounders and may be an additional target in the management of secondary hyperparathyroidism in CKD. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800639     DOI: 10.1016/j.metabol.2009.08.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Racial differences in parathyroid hormone levels in CKD.

Authors:  Tamara Isakova
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

Review 2.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

3.  Large artery stiffness and carotid intima-media thickness in relation to markers of calcium and bone mineral metabolism in African women older than 46 years.

Authors:  L F Gafane; R Schutte; I M Kruger; A E Schutte
Journal:  J Hum Hypertens       Date:  2014-08-14       Impact factor: 3.012

Review 4.  The Endocrine Role of Bone in Cardiometabolic Health.

Authors:  Rosemary DeLuccia; May Cheung; Rohit Ramadoss; Abeer Aljahdali; Deeptha Sukumar
Journal:  Curr Nutr Rep       Date:  2019-09

5.  Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; Melissa E Danko; Sandra Stinnett; Darshana Dixit; James Koh; Jeffrey R Marks; John A Olson
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Associations between serum leptin level and bone turnover in kidney transplant recipients.

Authors:  Csaba P Kovesdy; Miklos Z Molnar; Maria E Czira; Anna Rudas; Akos Ujszaszi; Laszlo Rosivall; Miklos Szathmari; Adrian Covic; Andras Keszei; Gabriella Beko; Peter Lakatos; Janos Kosa; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 8.237

7.  Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Authors:  Veronika Fedirko; Elio Riboli; H Bas Bueno-de-Mesquita; Sabina Rinaldi; Tobias Pischon; Teresa Norat; Eugène H J M Jansen; Fränzel J B van Duijnhoven; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Pierre Engel; Rudolf Kaaks; Birgit Teucher; Heiner Boeing; Brian Buijsse; Antonia Trichopoulou; Dimitrios Trichopoulos; Pagona Lagiou; Sabina Sieri; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Carla H van Gils; Petra H M Peeters; Maria-Dolores Chirlaque; Aurelio Barricarte Gurrea; Laudina Rodríguez; Esther Molina-Montes; Miren Dorronsoro; Catalina Bonet; Richard Palmqvist; Göran Hallmans; Timothy J Key; Konstantinos K Tsilidis; Kay-Tee Khaw; Isabelle Romieu; Kurt Straif; Petra A Wark; Dora Romaguera; Mazda Jenab
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-04       Impact factor: 4.254

8.  The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.

Authors:  Georges Saab; Andrew S Bomback; Samy I McFarlane; Suying Li; Shu-Cheng Chen; Peter A McCullough; Adam Whaley-Connell
Journal:  J Clin Endocrinol Metab       Date:  2012-10-12       Impact factor: 5.958

9.  Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants.

Authors:  Georges Saab; Shu-Cheng Chen; Suying Li; Andrew S Bomback; Adam T Whaley-Connell; Claudine T Jurkovitz; Keith C Norris; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2012-03       Impact factor: 8.860

10.  Obesity, anthropometric measures and chronic kidney disease complications.

Authors:  Sankar D Navaneethan; John P Kirwan; Susana Arrigain; Martin J Schreiber; Mark J Sarnak; Jesse D Schold
Journal:  Am J Nephrol       Date:  2012-08-28       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.